Atonarp

Molecular diagnostics company Atonarp scores $50M in Series D funding
By Thiru Gunasegaran | 12:25 am | May 21, 2021
The conpany uses its own spectroscopic technology to detect, analyse, and quantify molecular information.

MobiHealthNews

© current_year MobiHealthNews is a publication of HIMSS Media